tiprankstipranks
Medpace Holdings (MX:MEDP)
:MEDP
Mexico Market

Medpace Holdings (MEDP) Ratios

1 Followers

Medpace Holdings Ratios

MX:MEDP's free cash flow for Q2 2026 was $0.29. For the 2026 fiscal year, MX:MEDP's free cash flow was decreased by $ and operating cash flow was $0.20. See a summary of the company’s cash flow.
Ratios
TTM
Dec 25Dec 24Dec 23Dec 22
Liquidity Ratios
Current Ratio
0.73 0.74 0.93 0.64 0.42
Quick Ratio
0.73 0.74 0.93 0.64 0.42
Cash Ratio
0.35 0.37 0.61 0.27 0.04
Solvency Ratio
0.31 0.32 0.34 0.28 0.28
Operating Cash Flow Ratio
0.52 0.53 0.55 0.47 0.48
Short-Term Operating Cash Flow Coverage
0.00 30.73 26.14 0.00 7.76
Net Current Asset Value
$ -573.03M$ -526.78M$ -246.09M$ -504.05M$ -632.15M
Leverage Ratios
Debt-to-Assets Ratio
0.06 0.13 0.07 0.09 0.14
Debt-to-Equity Ratio
0.28 0.55 0.18 0.25 0.49
Debt-to-Capital Ratio
0.22 0.35 0.15 0.20 0.33
Long-Term Debt-to-Capital Ratio
0.00 0.20 0.00 0.00 0.00
Financial Leverage Ratio
4.74 4.30 2.54 2.96 3.50
Debt Service Coverage Ratio
0.00 20.65 18.62 635.82 4.98
Interest Coverage Ratio
0.00 0.00 0.00 690.22 95.94
Debt to Market Cap
0.00 <0.01 <0.01 0.00 <0.01
Interest Debt Per Share
4.24 8.68 4.83 4.64 5.92
Net Debt to EBITDA
-0.64 -0.43 -1.03 -0.28 0.53
Profitability Margins
Gross Profit Margin
28.76%30.06%31.12%27.81%29.62%
EBIT Margin
21.13%21.44%22.57%17.86%19.09%
EBITDA Margin
21.64%22.55%23.95%19.26%20.62%
Operating Profit Margin
20.97%21.14%21.19%17.86%19.09%
Pretax Profit Margin
21.53%21.44%22.57%17.80%19.37%
Net Profit Margin
17.67%17.83%19.17%15.00%16.81%
Continuous Operations Profit Margin
17.67%17.83%19.17%15.00%16.81%
Net Income Per EBT
82.06%83.18%84.97%84.25%86.75%
EBT Per EBIT
102.66%101.39%106.50%99.66%101.49%
Return on Assets (ROA)
23.89%22.84%19.25%17.07%18.14%
Return on Equity (ROE)
110.15%98.27%48.98%50.60%63.50%
Return on Capital Employed (ROCE)
93.83%84.68%44.85%46.03%50.76%
Return on Invested Capital (ROIC)
77.00%67.94%37.24%38.78%40.36%
Return on Tangible Assets
36.10%35.25%28.80%29.50%37.63%
Earnings Yield
2.96%2.78%3.93%3.00%3.57%
Efficiency Ratios
Receivables Turnover
6.30 6.29 7.11 6.32 5.76
Payables Turnover
52.82 62.88 44.66 42.72 31.07
Inventory Turnover
0.00 0.00 0.00 0.00 0.00
Fixed Asset Turnover
9.83 10.17 8.36 7.11 5.87
Asset Turnover
1.35 1.28 1.00 1.14 1.08
Working Capital Turnover Ratio
-9.41 -11.78 -10.37 -4.71 -8.70
Cash Conversion Cycle
51.05 52.20 43.13 49.21 51.60
Days of Sales Outstanding
57.96 58.00 51.30 57.75 63.35
Days of Inventory Outstanding
0.00 0.00 0.00 0.00 0.00
Days of Payables Outstanding
6.91 5.80 8.17 8.54 11.75
Operating Cycle
57.96 58.00 51.30 57.75 63.35
Cash Flow Ratios
Operating Cash Flow Per Share
26.59 24.73 19.67 14.11 11.98
Free Cash Flow Per Share
25.91 23.64 18.49 12.91 10.84
CapEx Per Share
0.68 1.09 1.18 1.19 1.14
Free Cash Flow to Operating Cash Flow
0.97 0.96 0.94 0.92 0.90
Dividend Paid and CapEx Coverage Ratio
39.30 22.75 16.66 11.83 10.52
Capital Expenditure Coverage Ratio
39.30 22.75 16.66 11.83 10.52
Operating Cash Flow Coverage Ratio
6.27 2.85 4.07 3.05 2.05
Operating Cash Flow to Sales Ratio
0.27 0.28 0.29 0.23 0.27
Free Cash Flow Yield
4.48%4.21%5.56%4.21%5.10%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
33.71 35.91 25.44 33.30 28.04
Price-to-Sales (P/S) Ratio
5.88 6.40 4.88 4.99 4.71
Price-to-Book (P/B) Ratio
38.25 35.29 12.46 16.85 17.80
Price-to-Free Cash Flow (P/FCF) Ratio
22.31 23.76 17.97 23.74 19.59
Price-to-Operating Cash Flow Ratio
22.05 22.72 16.89 21.73 17.73
Price-to-Earnings Growth (PEG) Ratio
1.31 1.82 0.61 1.55 0.57
Price-to-Fair Value
38.25 35.29 12.46 16.85 17.80
Enterprise Value Multiple
26.54 27.97 19.33 25.65 23.39
Enterprise Value
15.98B 15.95B 9.76B 9.31B 7.04B
EV to EBITDA
26.54 27.97 19.33 25.65 23.39
EV to Sales
5.74 6.31 4.63 4.94 4.82
EV to Free Cash Flow
21.79 23.40 17.06 23.48 20.05
EV to Operating Cash Flow
21.23 22.37 16.04 21.49 18.14
Tangible Book Value Per Share
-9.24 -8.21 4.16 -4.53 -9.70
Shareholders’ Equity Per Share
15.33 15.91 26.67 18.19 11.93
Tax and Other Ratios
Effective Tax Rate
0.18 0.17 0.15 0.16 0.13
Revenue Per Share
98.29 87.72 68.13 61.38 45.08
Net Income Per Share
17.36 15.64 13.06 9.21 7.58
Tax Burden
0.82 0.83 0.85 0.84 0.87
Interest Burden
1.02 1.00 1.00 1.00 1.01
Research & Development to Revenue
0.00 0.00 0.00 0.00 0.00
SG&A to Revenue
0.07 0.08 0.09 0.00 0.00
Stock-Based Compensation to Revenue
<0.01 0.01 0.01 0.01 0.01
Income Quality
1.53 1.58 1.51 1.53 1.58
Currency in USD